Meta-Analysis of the Outcome After Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation in Adult Patients

Standard

Meta-Analysis of the Outcome After Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation in Adult Patients. / Biancari, Fausto; Perrotti, Andrea; Dalén, Magnus; Guerrieri, Mariapia; Fiore, Antonio; Reichart, Daniel; Dell'Aquila, Angelo M; Gatti, Giuseppe; Ala-Kokko, Tero; Kinnunen, Eeva-Maija; Tauriainen, Tuomas; Chocron, Sidney; Airaksinen, Juhani K E; Ruggieri, Vito G; Brascia, Debora.

in: J CARDIOTHOR VASC AN, Jahrgang 32, Nr. 3, 06.2018, S. 1175-1182.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ReviewForschung

Harvard

Biancari, F, Perrotti, A, Dalén, M, Guerrieri, M, Fiore, A, Reichart, D, Dell'Aquila, AM, Gatti, G, Ala-Kokko, T, Kinnunen, E-M, Tauriainen, T, Chocron, S, Airaksinen, JKE, Ruggieri, VG & Brascia, D 2018, 'Meta-Analysis of the Outcome After Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation in Adult Patients', J CARDIOTHOR VASC AN, Jg. 32, Nr. 3, S. 1175-1182. https://doi.org/10.1053/j.jvca.2017.08.048

APA

Biancari, F., Perrotti, A., Dalén, M., Guerrieri, M., Fiore, A., Reichart, D., Dell'Aquila, A. M., Gatti, G., Ala-Kokko, T., Kinnunen, E-M., Tauriainen, T., Chocron, S., Airaksinen, J. K. E., Ruggieri, V. G., & Brascia, D. (2018). Meta-Analysis of the Outcome After Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation in Adult Patients. J CARDIOTHOR VASC AN, 32(3), 1175-1182. https://doi.org/10.1053/j.jvca.2017.08.048

Vancouver

Bibtex

@article{c928e70f2ffa4234b28f9198d951e153,
title = "Meta-Analysis of the Outcome After Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation in Adult Patients",
abstract = "OBJECTIVE: This study was planned to pool existing data on outcome and to evaluate the efficacy of postcardiotomy venoarterial extracorporeal membrane oxygenation (VA-ECMO) in adult patients.DESIGN: Systematic review of the literature and meta-analysis.SETTING: Multi-institutional study.PARTICIPANTS: Adult patients with acute heart failure immediately after cardiac surgery.INTERVENTIONS: VA-ECMO after cardiac surgery. Studies evaluating only heart transplant patients were excluded from this analysis.MEASUREMENTS AND MAIN RESULTS: A literature search was performed to identify studies published since 2000. Thirty-one studies reported on 2,986 patients (mean age, 58.1 years) who required postcardiotomy VA-ECMO. The weaning rate from VA-ECMO was 59.5% and hospital survival was 36.1% (95% CI 31.5-40.8). The pooled rate of reoperation for bleeding was 42.9%, major neurological event 11.3%, lower limb ischemia 10.8%, deep sternal wound infection/mediastinitis 14.7%, and renal replacement therapy 47.1%. The pooled mean number of transfused red blood cell units was 17.7 (95% CI 13.3-22.1). The mean stay in the intensive care unit was 13.3 days (95% CI 10.2-16.4). Survivors were significantly younger (mean, 55.7 v 63.6 years, p = 0.015) and their blood lactate level before starting VA-ECMO was lower (mean, 7.7 v 10.7 mmol/L, p = 0.028) than patients who died. One-year survival rate was 30.9% (95% CI 24.3-37.5).CONCLUSIONS: Pooled data showed that VA-ECMO may salvage one-third of patients unresponsive to any other resuscitative treatment after adult cardiac surgery.",
keywords = "Adult, Cardiac Surgical Procedures/adverse effects, Extracorporeal Membrane Oxygenation/mortality, Heart Failure/etiology, Humans, Postoperative Complications/etiology, Survival Rate/trends, Treatment Outcome",
author = "Fausto Biancari and Andrea Perrotti and Magnus Dal{\'e}n and Mariapia Guerrieri and Antonio Fiore and Daniel Reichart and Dell'Aquila, {Angelo M} and Giuseppe Gatti and Tero Ala-Kokko and Eeva-Maija Kinnunen and Tuomas Tauriainen and Sidney Chocron and Airaksinen, {Juhani K E} and Ruggieri, {Vito G} and Debora Brascia",
note = "Copyright {\textcopyright} 2017 Elsevier Inc. All rights reserved.",
year = "2018",
month = jun,
doi = "10.1053/j.jvca.2017.08.048",
language = "English",
volume = "32",
pages = "1175--1182",
journal = "J CARDIOTHOR VASC AN",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "3",

}

RIS

TY - JOUR

T1 - Meta-Analysis of the Outcome After Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation in Adult Patients

AU - Biancari, Fausto

AU - Perrotti, Andrea

AU - Dalén, Magnus

AU - Guerrieri, Mariapia

AU - Fiore, Antonio

AU - Reichart, Daniel

AU - Dell'Aquila, Angelo M

AU - Gatti, Giuseppe

AU - Ala-Kokko, Tero

AU - Kinnunen, Eeva-Maija

AU - Tauriainen, Tuomas

AU - Chocron, Sidney

AU - Airaksinen, Juhani K E

AU - Ruggieri, Vito G

AU - Brascia, Debora

N1 - Copyright © 2017 Elsevier Inc. All rights reserved.

PY - 2018/6

Y1 - 2018/6

N2 - OBJECTIVE: This study was planned to pool existing data on outcome and to evaluate the efficacy of postcardiotomy venoarterial extracorporeal membrane oxygenation (VA-ECMO) in adult patients.DESIGN: Systematic review of the literature and meta-analysis.SETTING: Multi-institutional study.PARTICIPANTS: Adult patients with acute heart failure immediately after cardiac surgery.INTERVENTIONS: VA-ECMO after cardiac surgery. Studies evaluating only heart transplant patients were excluded from this analysis.MEASUREMENTS AND MAIN RESULTS: A literature search was performed to identify studies published since 2000. Thirty-one studies reported on 2,986 patients (mean age, 58.1 years) who required postcardiotomy VA-ECMO. The weaning rate from VA-ECMO was 59.5% and hospital survival was 36.1% (95% CI 31.5-40.8). The pooled rate of reoperation for bleeding was 42.9%, major neurological event 11.3%, lower limb ischemia 10.8%, deep sternal wound infection/mediastinitis 14.7%, and renal replacement therapy 47.1%. The pooled mean number of transfused red blood cell units was 17.7 (95% CI 13.3-22.1). The mean stay in the intensive care unit was 13.3 days (95% CI 10.2-16.4). Survivors were significantly younger (mean, 55.7 v 63.6 years, p = 0.015) and their blood lactate level before starting VA-ECMO was lower (mean, 7.7 v 10.7 mmol/L, p = 0.028) than patients who died. One-year survival rate was 30.9% (95% CI 24.3-37.5).CONCLUSIONS: Pooled data showed that VA-ECMO may salvage one-third of patients unresponsive to any other resuscitative treatment after adult cardiac surgery.

AB - OBJECTIVE: This study was planned to pool existing data on outcome and to evaluate the efficacy of postcardiotomy venoarterial extracorporeal membrane oxygenation (VA-ECMO) in adult patients.DESIGN: Systematic review of the literature and meta-analysis.SETTING: Multi-institutional study.PARTICIPANTS: Adult patients with acute heart failure immediately after cardiac surgery.INTERVENTIONS: VA-ECMO after cardiac surgery. Studies evaluating only heart transplant patients were excluded from this analysis.MEASUREMENTS AND MAIN RESULTS: A literature search was performed to identify studies published since 2000. Thirty-one studies reported on 2,986 patients (mean age, 58.1 years) who required postcardiotomy VA-ECMO. The weaning rate from VA-ECMO was 59.5% and hospital survival was 36.1% (95% CI 31.5-40.8). The pooled rate of reoperation for bleeding was 42.9%, major neurological event 11.3%, lower limb ischemia 10.8%, deep sternal wound infection/mediastinitis 14.7%, and renal replacement therapy 47.1%. The pooled mean number of transfused red blood cell units was 17.7 (95% CI 13.3-22.1). The mean stay in the intensive care unit was 13.3 days (95% CI 10.2-16.4). Survivors were significantly younger (mean, 55.7 v 63.6 years, p = 0.015) and their blood lactate level before starting VA-ECMO was lower (mean, 7.7 v 10.7 mmol/L, p = 0.028) than patients who died. One-year survival rate was 30.9% (95% CI 24.3-37.5).CONCLUSIONS: Pooled data showed that VA-ECMO may salvage one-third of patients unresponsive to any other resuscitative treatment after adult cardiac surgery.

KW - Adult

KW - Cardiac Surgical Procedures/adverse effects

KW - Extracorporeal Membrane Oxygenation/mortality

KW - Heart Failure/etiology

KW - Humans

KW - Postoperative Complications/etiology

KW - Survival Rate/trends

KW - Treatment Outcome

U2 - 10.1053/j.jvca.2017.08.048

DO - 10.1053/j.jvca.2017.08.048

M3 - SCORING: Review article

C2 - 29158060

VL - 32

SP - 1175

EP - 1182

JO - J CARDIOTHOR VASC AN

JF - J CARDIOTHOR VASC AN

SN - 1053-0770

IS - 3

ER -